Lalitha Shankar

80 papers · 26.2k indexed citations

Standout Papers

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) (2008)
E. Eisenhauer, P. Therasse et al. European Journal of Cancer
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics (2017)
Lesley Seymour, Jan Bogaerts et al. The Lancet Oncology
RECIST 1.1—Update and clarification: From the RECIST committee (2016)
Lawrence H. Schwartz, Saskia Litière et al. European Journal of Cancer
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. (2006)
Lalitha Shankar, John M. Hoffman et al. PubMed
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development (2005)
Gary J. Kelloff, John M. Hoffman et al. Clinical Cancer Research
Criteria for the translation of radiomics into clinically useful tests (2022)
Erich P. Huang, James P.B. O’Connor et al. Nature Reviews Clinical Oncology

7 by Nobel laureates 7 from Science/Nature 58 standout

Sub-graph 1 of 22

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

2024 Standout

Ponsegromab for the Treatment of Cancer Cachexia

2024 Standout

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

2008 Standout

Author					Papers	Cites
Lalitha Shankar	6048	4624	11141	13358	80	26.2k
P. Therasse	4515	4066	10292	12124	57	23.4k
Lori E. Dodd	4270	4093	9290	11163	69	23.4k
E. Eisenhauer	4174	4001	9540	11648	62	22.0k
Margaret Mooney	4017	3977	9599	11837	61	22.3k
Jan Bogaerts	5096	5187	11721	15815	113	29.2k
Stephen J. Gwyther	4390	4221	10068	12130	30	22.7k
Patrick Therasse	3223	3195	8536	10686	36	20.2k
Allan T. van Oosterom	2362	4253	10029	9266	88	21.6k
Denis Lacombe	6891	4585	13920	14887	113	39.9k
Susan G. Arbuck	6206	6754	16266	21461	88	39.7k

Loading papers...